Hennion & Walsh Asset Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.6M Buy
28,507
+1,235
+5% +$163K 0.1% 248
2026
Q1
$3.8M Buy
27,272
+5,866
+27% +$821K 0.13% 208
2025
Q4
$2.63M Buy
21,406
+3,288
+18% +$400K 0.09% 289
2025
Q3
$2.01M Buy
18,118
+5,506
+44% +$626K 0.07% 345
2025
Q2
$1.4M Buy
12,612
+232
+2% +$24.7K 0.06% 407
2025
Q1
$1.39M Buy
12,380
+1,143
+10% +$118K 0.06% 381
2024
Q4
$1.04M Sell
11,237
-5,633
-33% -$507K 0.05% 460
2024
Q3
$1.41M Sell
16,870
-7,644
-31% -$583K 0.07% 370
2024
Q2
$1.68M Sell
24,514
-4,030
-14% -$269K 0.09% 291
2024
Q1
$2.09M Sell
28,544
-6,415
-18% -$493K 0.11% 249
2023
Q4
$2.83M Sell
34,959
-578
-2% -$45K 0.16% 182
2023
Q3
$2.66M Sell
35,537
-1,250
-3% -$96.1K 0.17% 161
2023
Q2
$2.83M Buy
36,787
+218
+0.6% +$17.4K 0.17% 160
2023
Q1
$3.03M Buy
36,569
+2,691
+8% +$223K 0.19% 144
2022
Q4
$2.91M Buy
33,878
+6,880
+25% +$545K 0.18% 150
2022
Q3
$1.67M Buy
26,998
+6,696
+33% +$422K 0.11% 219
2022
Q2
$1.25M Buy
20,302
+7,518
+59% +$465K 0.08% 263
2022
Q1
$760K Buy
12,784
+4,870
+62% +$311K 0.04% 412
2021
Q4
$575K Buy
7,914
+2,325
+42% +$160K 0.03% 508
2021
Q3
$390K Buy
5,589
+464
+9% +$32.6K 0.02% 572
2021
Q2
$353K Buy
5,125
+370
+8% +$24.7K 0.02% 581
2021
Q1
$307K Buy
+4,755
New +$307K 0.02% 594

Other funds holding GILD

Hennion & Walsh Asset Management's GILD Position: Q2 2026 in Review

Hennion & Walsh Asset Management increased its Gilead Sciences (GILD) stake by 4.5% in Q2 2026, buying an estimated $163K and bringing the position to 28,507 shares worth $3.6M. The position accounts for 0.1% of the portfolio, ranked #248.

Hennion & Walsh Asset Management first reported a position in GILD in Q1 2021 and has held it in 22 quarters since. The position peaked at $3.8M in Q1 2026. 690 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Hennion & Walsh Asset Management held 28,507 shares of Gilead Sciences worth $3.6M as of Q2 2026.
  • Hennion & Walsh Asset Management bought 1,235 Gilead Sciences shares in Q2 2026, an estimated $163K.
  • Gilead Sciences made up 0.1% of Hennion & Walsh Asset Management's portfolio in Q2 2026, its #248 holding.
  • Hennion & Walsh Asset Management first reported a position in Gilead Sciences in Q1 2021 and has held it in 22 quarters since.
  • Hennion & Walsh Asset Management's Gilead Sciences position peaked at $3.8M in Q1 2026.
  • 690 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Hennion & Walsh Asset Management's 13F filing for Q2 2026, filed 8 Jul 2026.